Synonym
Fludarabine-Cl; ZYS-1;
IUPAC/Chemical Name
(2R,3R,4S,5S)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(chloromethyl)tetrahydrofuran-3,4-diol
InChi Key
HSCKXTNMVCTWGY-UUOKFMHZSA-N
InChi Code
InChI=1S/C10H11ClFN5O3/c11-1-3-5(18)6(19)9(20-3)17-2-14-4-7(13)15-10(12)16-8(4)17/h2-3,5-6,9,18-19H,1H2,(H2,13,15,16)/t3-,5-,6-,9-/m1/s1
SMILES Code
NC1=C2C(N([C@]3([H])O[C@@H]([C@H]([C@H]3O)O)CCl)C=N2)=NC(F)=N1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
303.68
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Wang X, Li J, Zhu Y, Shen H, Ding J, Zeng T, Min W, Liang SQ, Huang L, Shi Z,
Shen H, Huang F, Yuan K, Kuang W, Ji M, Sun C, Hou Y, Wang L, Chen W, Jiang Y,
Hao H, Xiao Y, Yang P. Targeting ADAR1 with a small molecule for the treatment
of prostate cancer. Nat Cancer. 2025 Mar;6(3):474-492. doi:
10.1038/s43018-025-00907-4. Epub 2025 Feb 10. PMID: 39930013.
2: Shi Z, Li J, Ding J, Zhang Y, Min W, Zhu Y, Hou Y, Yuan K, Sun C, Wang X,
Shen H, Wang L, Liang SQ, Kuang W, Wang X, Yang P. ADAR1 is required for acute
myeloid leukemia cell survival by modulating post-transcriptional Wnt signaling
through impairing miRNA biogenesis. Leukemia. 2025 Mar;39(3):599-613. doi:
10.1038/s41375-024-02500-7. Epub 2024 Dec 19. PMID: 39702795.
